BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9830966)

  • 21. Atorvastatin and portal pressure.
    Zamora-Valdés D; Uribe M; Méndez-Sánchez N
    Hepatology; 2007 Oct; 46(4):1309-10; author reply 1310. PubMed ID: 17894304
    [No Abstract]   [Full Text] [Related]  

  • 22. Early intervention with atorvastatin modulates TH1/TH2 imbalance in patients with acute coronary syndrome: from bedside to bench.
    Shimada K; Miyauchi K; Daida H
    Circulation; 2004 May; 109(18):e213-4; author reply e213-4. PubMed ID: 15136515
    [No Abstract]   [Full Text] [Related]  

  • 23. [Endothelial dysfunction, inflammation and statins: new evidences].
    Tuñón J; Egido J
    Rev Esp Cardiol; 2004 Oct; 57(10):903-5. PubMed ID: 15469785
    [No Abstract]   [Full Text] [Related]  

  • 24. Atorvastatin: in the management of hyperlipidaemia.
    Ray SK; Rege NN
    J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482
    [No Abstract]   [Full Text] [Related]  

  • 25. Atorvastatin: a new agent for hyperlipidemia.
    Kupecz D
    Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876
    [No Abstract]   [Full Text] [Related]  

  • 26. [Atorvastatin dreduces sympathetic activity and improves baroreceptor reflex sensitivity in patients with hypercholesterolemia and hypertension].
    Raczak G
    Kardiol Pol; 2009 Jun; 67(6):621-2. PubMed ID: 19852090
    [No Abstract]   [Full Text] [Related]  

  • 27. Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease.
    Isaacsohn JL; Davidson MH; Hunninghake D; Singer R; McLain R; Black DM
    Am J Cardiol; 2000 Jul; 86(2):250-2. PubMed ID: 10913499
    [No Abstract]   [Full Text] [Related]  

  • 28. Atorvastatin and glatiramer acetate: new hope in MS?
    Bradbury J
    Lancet Neurol; 2006 May; 5(5):386-7. PubMed ID: 16639832
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of atorvastatin on plasma fibrinogen.
    Wierzbicki AS; Lumb PJ; Semra YK; Crook MA
    Lancet; 1998 Feb; 351(9102):569-70. PubMed ID: 9492781
    [No Abstract]   [Full Text] [Related]  

  • 30. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study.
    Galin ID; Smith DA
    Am Heart J; 2006 May; 151(5):e1. PubMed ID: 16644302
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fluvastatin in a comparative study. Are there substance-specific differences between various CSE-inhibitors?].
    Internist (Berl); 1999 Mar; 40(3 Suppl Gibt Es):1-4. PubMed ID: 10192028
    [No Abstract]   [Full Text] [Related]  

  • 32. The nature of the statins.
    Jones PH
    Circulation; 2000 Feb; 101(8):E89. PubMed ID: 10694539
    [No Abstract]   [Full Text] [Related]  

  • 33. Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia.
    Majima T; Komatsu Y; Fukao A; Ninomiya K; Matsumura T; Nakao K
    Endocr J; 2007 Feb; 54(1):145-51. PubMed ID: 17185879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of atorvastatin in the treatment of hypercholesterolemia associated with antiretroviral therapy.
    Palacios R; Santos J; González M; Ruiz J; Valdivielso P; Márquez M; González-Santos P
    J Acquir Immune Defic Syndr; 2002 Aug; 30(5):536-7. PubMed ID: 12154347
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of severe hypercholesterolemia with atorvastatin in congenital analbuminemia.
    Del Ben M; Burattin M; Arca M; Ceci F; Violi F; Angelico F
    Am J Med; 2004 Nov; 117(10):803-4. PubMed ID: 15541334
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and safety of chunghyul-dan (qingwie-dan) in patients with hypercholesterolemia.
    Cho KH; Kang HS; Jung WS; Park SU; Moon SK
    Am J Chin Med; 2005; 33(2):241-8. PubMed ID: 15974483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia.
    Ercan E; Tengiz I; Altuglu I; Sekuri C; Aliyev E; Ercan HE; Akin M
    Kardiol Pol; 2004 May; 60(5):454-8. PubMed ID: 15247960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.
    Wamhoff BR; Dixon JL; Sturek M
    J Vasc Res; 2002; 39(3):208-20. PubMed ID: 12097819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atorvastatin therapy associated with improvement in left ventricular remodeling in a case of idiopathic dilated cardiomyopathy.
    Yamada T; Node K; Mine T; Morita T; Kioka H; Tamaki S; Tsukamoto Y; Masuda M; Okuda K; Fukunami M
    Am J Med Sci; 2006 Dec; 332(6):361-3. PubMed ID: 17170629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term effects of atorvastatin on haemorheologic parameters, platelet aggregation and endothelium dysfunction in patients with hypercholesterolaemia.
    Horvath B; Marton Z; Alexy T; Kesmarky G; Toth K; Szapary L
    Eur Heart J; 2004 Jan; 25(1):96. PubMed ID: 14683748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.